Supply of Nivolumab for Medical Use

This contract involves the supply of the pharmaceutical product Nivolumab, which is used for medical treatments. The specific requirements include: - Nivolumab concentrate for preparing an infusion solution at a concentration of 10 mg/ml in 4 ml vials, with a total of 4,000 vials required. - Nivolumab concentrate for preparing an infusion solution at a concentration of 10 mg/ml in 10 ml vials, with a total of 2,000 vials required. The total value of the contract is approximately €24,379,833.60. This opportunity is published on the TED platform and is managed by the Institute of Tuberculosis and Lung Diseases in Poland.